Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, and the securities litigation firm of Powers Taylor LLP announce that a federal class action lawsuit has been filed in the United States District Court for the Eastern District of Michigan against Esperion Therapeutics, Inc. (“Esperion”) (NASDAQ: ESPR) and several officers and directors for acts taken during the period of August 18, 2015 and September 28, 2015 (the “Class Period”).

Shareholders who suffered a loss during the class period have until March 14, 2016 to seek appointment as lead plaintiff. If you lost more than $100,000.00 from shares purchased during the class period and wish to take a more proactive role in the litigation, you are urged to contact Willie Briscoe at The Briscoe Law Firm, PLLC via email at shareholders@thebriscoelawfirm.com, Patrick Powers at Powers Taylor LLP via email at shareholder@powerstaylor.com, or call toll free at (877) 728-9607. There is no cost or fee to you.

According to the complaint, the defendants are alleged to have violated certain provisions of the Securities Exchange Act of 1934. Specifically, the complaint alleges, that Esperion issued false and misleading statements and failed to disclose that it had no clear path to approval for ETC-1002, the Company’s lead product candidate designed to lower LDL-cholesterol levels. On August 17, 2015, Esperion reported to investors material events from an August 2015 meeting with the FDA, stating that the Company was informed by the FDA during the meeting that it would not have to complete a CVOT to gain approval of ETC-1002. Then, on September 28, 2015, Esperion issued a press release noting that the FDA had encouraged it to initiate a cardiovascular outcomes trial (“CVOT”) and that completion of a CVOT could be necessary prior to approval of ETC-1002. Esperion stock dropped significantly immediately following this announcement.

The Briscoe Law Firm, PLLC is a full service business litigation, commercial transaction, and public advocacy firm with more than 20 years of experience in complex litigation and transactional matters.

Powers Taylor LLP is a boutique litigation law firm that handles a variety of complex business litigation matters, including claims of investor and stockholder fraud, shareholder oppression, shareholder derivative suits, and security class actions.

The Briscoe Law Firm, PLLCWillie Briscoe, 877-728-9607shareholders@thebriscoelawfirm.comorPowers Taylor LLPPatrick Powers, 877-728-9607shareholder@powerstaylor.com

Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Esperion Therapeutics Charts.
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Esperion Therapeutics Charts.